JETEMA, Co., Ltd. (KOSDAQ: A216080)
Health Care · Pharmaceuticals · KR
₩5,030.00
+17.94% today · -16.6% 1Y
JETEMA, Co., Ltd. (KOSDAQ: A216080) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $135.33M.
Over the last twelve months the share price has lost 16.6%, trading between 3.80K and 11.28K.
Tweenvest scores JETEMA, Co., Ltd. across four factors: quality 44/100, value 65/100. Its strongest factor is value.
A216080 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $135.33M
- Revenue (TTM)
- $50.63M
- P/E
- —
- EPS
- -140.70
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- ₩11,280.00
- 52-week low
- ₩3,800.00
- Avg volume (3M)
- —
- Shares outstanding
- 37.29M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.